
An overview of the largest study to examine persistent pulmonary hypertension in newborns (PPHN) exposed to antidepressants late in pregnancy.

An overview of the largest study to examine persistent pulmonary hypertension in newborns (PPHN) exposed to antidepressants late in pregnancy.

Combination buspirone and melatonin exert therapeutic cognitive effects that are distinct from their antidepressant effects, according to a recent study.

Renal failure is not an uncommon disorder either in the general public or in patients with psychiatric disorders, but accompanying depression, anxiety, and loss must be attended to during such an illness.

Findings on mood disorders, and the disability associated with it, speak to the need for effective treatments for depression.

Depression and diabetes can prey on the shortcomings of our health care system, such as fragmented, episodic care and poor continuity. Coordinating care can be fraught with difficulties, but it is the goal of many current efforts in health care reform.

Identifying patients who are likely to relapse despite continued, maintenance cognitive therapy can help optimize management of MDD and also help ensure efficient use of healthcare resources.

A 2-year study found a threefold increased risk of cardiovascular disease in older patients with major depression.

College mental health is not just a matter of identifying problems but also of creating a community of students, families, friends, mental health professionals, faculty advisors, and many others to help students gain psychological resiliency.

Which one is Selective Serotonin and which is Reuptake Inhibitor? Some Friday fun.

Like the body’s inevitable arrival at homeostasis, a bereaved person's mind settles-eventually. A peer-to-peer conversation from someone who has been there.

Is it possible to add creative twists to proven therapeutic techniques in order to encourage reluctant patients to try safe and effective treatments that we believe can benefit them? After reading the case, tell us what you think.

A case report of an acute, transient, reversible depression prompts us to think in a different way about depression.

Do persons with depression and a history of early life trauma benefit more from psychotherapy or pharmacotherapy? Take the quiz and learn more.

The articles in this Special Report address suicidal behavior in the context of the role of sexual identity, the effects of antidepressants and lithium on suicidal behavior, and clinicians’ reactions in the aftermath of suicide.

As an occupational hazard, preparing for the possibility of patient suicide will help the clinician anticipate the types of support that our colleagues or we may need to weather the event.

Through archival footage and interviews, the documentary "Prozac: Revolution in a Capsule" does a remarkable job of capturing the time when transformation ignited the collective imagination.

Are suicide rates higher or lower during holidays such as Thanksgiving and Christmas? Take the quiz and learn more.

What percentage of patients hospitalized for depression eventually die by suicide? Learn more in this quiz.

What percentage of depressed patients are resistant to treatment with conventional antidepressant medication?

Clinicians will likely encounter increasing numbers of older adults with late-life depression. Advances in our understanding of the neurobiology can help inform diagnosis and prognosis.

Patients with severe depression are more likely to have symptom remission with a combination of cognitive therapy and antidepressant medication than those with less severe or more chronic illness.

In this video, Dr Andrew Solomon talks about how psychiatrists and psychologists can help depressed or traumatized patients foster resilience, without trivializing their pain.

What to do once treatment-resistant depression is established based on risk factors and exclusion of other conditions? Insights here-and a treatment algorithm.

The discovery that a single IV infusion of low-dose (subanesthetic) ketamine exerts rapid antidepressant effects constitutes an expansion in our understanding of the neurobiology of depression and provides new avenues for drug development.

Chronobiology-the science of daily (circadian), monthly, tidal, and seasonal rhythms-has undergone exponential growth in the past decade, with major discoveries at the molecular and neuroanatomic level.